RECQL4 and gastric cancer: In the setting of elevated endogenous RECQL4, silencing of ectopic RECQL4 in cisplatin-resistant gastric cancer cells led to reduced activation of this pathway and subsequent resensitization to cisplatin (Mo et al., 2016).